Amgen expects approval for Xgeva as bone treatment in April
Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →
Experts tackle making money off digital music and movies
How technology is reshaping the entrainment business will be the focus of a panel discussion called “Making Money Off Media: The Future of Creativity in the Digital Age” on Wednesday, Aug. 24 in Pismo Beach.
10-K report: Vitesse looks for profitability
In the space of a decade, Vitesse Semiconductor Corp. fell from the throne of a blue-chip stock to a largely unprofitable player in the communications industry.
Study targets diabetes
New research conducted on the South Coast could point the way to the prevention and cure of type two diabetes.
Yardi buys insurance firm
Real estate software firm Yardi Systems said Aug. 16 that it has purchased Dallas-based Multifamily Insurance Group.
Court orders China to face lawsuit claims
A federal judge has said that Chinese firms being sued by a Santa Barbara software company cannot escape court proceedings in the United States after allegedly stealing the California company’s code.
Read this column on paper or in pixels
For the first time since the founding of the Business Times in 2000, this technology column — along with the rest of the paper’s weekly news reports — will be available in its entirety on the Internet.
